Expert Opinion on Drug Delivery,
Journal Year:
2024,
Volume and Issue:
21(8), P. 1191 - 1211
Published: Aug. 2, 2024
Wounds,
resulting
from
traumas,
surgery,
burns
or
diabetes,
are
important
medical
problems
due
to
the
complexity
of
wound
healing
process
regarding
times
and
healthcare
costs.
Nanosystems
have
emerged
as
promising
candidates
in
this
field
thank
their
properties
versatile
applications
drugs
delivery.
Frontiers in Pharmacology,
Journal Year:
2023,
Volume and Issue:
14
Published: Sept. 6, 2023
Cancer
has
remained
one
of
the
leading
causes
death
worldwide,
with
a
lack
effective
treatment.
The
intrinsic
shortcomings
conventional
therapeutics
regarding
tumor
specificity
and
non-specific
toxicity
prompt
us
to
look
for
alternative
mitigate
these
limitations.
In
this
regard,
we
developed
multifunctional
bimetallic
(FeCo)
bi-MIL-88B-FC
MOFs
modified
folic
acid-conjugated
chitosan
(FC)
as
drug
delivery
systems
(DDS)
targeted
5-Fluorouracil
(5-FU).
bi-MIL-88B
nanocarriers
were
characterized
through
various
techniques,
including
powder
X-ray
diffraction,
scanning
electron
microscopy,
energy-dispersive
X-ray,
thermogravimetric
analysis,
Fourier
transform
infrared
spectroscopy.
Interestingly,
5-FU@bi-MIL-88B-FC
showed
slower
release
5-FU
due
gated
effect
phenomenon
endowed
by
FC
surface
coating
compared
un-modified
5-FU@bi-MIL-88B.
pH-responsive
was
observed,
58%
loaded
released
in
cancer
cells
mimicking
pH
(5.2)
only
24.9%
under
physiological
(5.4).
vitro
cytotoxicity
cellular
internalization
experiments
revealed
superiority
highly
potent
DDS
against
folate
receptor
(FR)
positive
SW480
cells.
Moreover,
presence
Fe
Co
structure,
exhibited
peroxidase-like
activity
chemodynamic
therapy.
Based
on
results,
could
serve
promising
candidate
smart
sustained
selective
targeting.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(4), P. 2165 - 2165
Published: Feb. 10, 2024
The
incidence
of
skin
cancer
continues
to
grow.
There
are
an
estimated
1.5
million
new
cases
each
year,
which
nearly
350,000
melanoma,
is
often
fatal.
Treatment
challenging
and
ineffective,
with
conventional
chemotherapy
playing
a
limited
role
in
this
context.
These
disadvantages
can
be
overcome
by
the
use
nanoparticles
may
allow
for
early
detection
monitoring
neoplastic
changes
determining
effectiveness
treatment.
This
article
briefly
reviews
present
understanding
characteristics
cancers,
their
epidemiology,
risk
factors.
It
also
outlines
possibilities
using
nanotechnology,
especially
nanoparticles,
transport
medicinal
substances.
Research
over
previous
decade
on
carriers
active
substances
indicates
that
drugs
delivered
more
accurately
tumor
site,
resulting
higher
therapeutic
efficacy.
describes
application
liposomes,
carbon
nanotubes,
metal
polymer
existing
therapies.
discusses
challenges
encountered
nanoparticle
therapy
improving
performance.
Undoubtedly,
promising
method
help
fight
against
cancer.
Pharmaceutics,
Journal Year:
2024,
Volume and Issue:
16(1), P. 115 - 115
Published: Jan. 16, 2024
In
modern
pharmaceutical
technology,
modified-release
dosage
forms,
such
as
in
situ
formed
implants,
are
gaining
rapidly
popularity.
These
forms
created
based
on
a
configurable
matrix
consisting
of
phase-sensitive
polymers
capable
biodegradation,
hydrophilic
solvent,
and
the
active
substance
suspended
or
dissolved
it.
The
most
used
implants
biocompatible
biodegradable
polymer,
poly(DL-lactide-co-glycolide)
(PLGA).
Objective:
This
systematic
review
examines
reasons
for
phenomenon
ingredient
“burst”
release,
which
is
major
drawback
PLGA-based
likely
ways
to
correct
this
improve
quality
with
matrix.
Data
sources:
Actual
relevant
publications
PubMed
Google
Scholar
databases
were
studied.
Study
selection:
concept
was
theory
developed
during
literature
analysis
12
effectors
burst
release
from
forming
PLGA.
Only
those
studies
that
sufficiently
fully
disclosed
one
another
component
included.
Results:
resulted
development
approach
called
“12
Factor
System”,
considers
various
constant
variable,
endogenous
exogenous
factors
can
influence
nature
‘burst
release’
ingredients
PLGA
polymer-based
implants.
include
porosity,
polymer
swelling,
LA:GA
ratio,
end
groups,
molecular
weight,
structure,
concentration,
loading
ingredients,
combination,
use
co-solvents,
addition
excipients,
change
dissolution
conditions.
also
considered
different
types
kinetics
possibility
using
“burst
release”
modify
profile
at
site
application
form.
ACS Applied Materials & Interfaces,
Journal Year:
2024,
Volume and Issue:
16(12), P. 15533 - 15547
Published: Feb. 15, 2024
Microrobots
are
of
significant
interest
due
to
their
smart
transport
capabilities,
especially
for
precisely
targeted
delivery
in
dynamic
environments
(blood,
cell
membranes,
tumor
interstitial
matrixes,
blood–brain
barrier,
mucosa,
and
other
body
fluids).
To
perform
a
more
complex
micromanipulation
biological
applications,
it
is
highly
desirable
microrobots
be
stimulated
with
multiple
stimuli
rather
than
single
stimulus.
Herein,
the
biodegradable
biocompatible
micromotors
Janus
architecture
consisting
PrecirolATO
5
polycaprolactone
compartments
inspired
by
anisotropic
geometry
tadpoles
sperms
newly
designed.
These
bioinspired
combine
advantageous
properties
polypyrrole
nanoparticles
(NPs),
high
near-infrared
light-absorbing
agent
photothermal
conversion
efficiency,
magnetic
NPs,
which
respond
field
exhibit
multistimulus-responsive
behavior.
By
combining
both
fields,
we
achieved
an
"on/off"
propulsion
mechanism
that
can
enable
us
overcome
tasks
limitations
liquid
encountered
actuation
applications.
Moreover,
particles
offer
functions
such
as
removing
organic
pollutants
via
Fenton
reaction.
Janus-structured
motors
provide
broad
perspective
not
only
biosensing,
optical
detection,
on-chip
separation
applications
but
also
environmental
water
treatment
catalytic
activities
micromotors.
Gels,
Journal Year:
2024,
Volume and Issue:
10(5), P. 307 - 307
Published: May 1, 2024
Nanostructured
lipid
carriers
(NLCs)
have
the
potential
to
increase
bioavailability
and
reduce
side
effects
of
docetaxel
(DTX).
However,
only
a
small
fraction
nanoparticles
given
intravenously
can
reach
solid
tumor.
In
situ-forming
gels
combined
with
facilitate
local
administration
promote
drug
retention
at
tumor
site.
Injectable
hydrogels
based
on
poloxamer
407
are
excellent
candidates
for
this
hybrid
nanoparticle-hydrogel
system
because
their
thermoresponsive
behavior
biocompatibility.
Therefore,
work
aimed
develop
injectable
containing
NLCs
intratumoral
delivery
DTX.
To
ensure
sterility,
obtained
were
autoclaved
(121
°C
15
min)
after
preparation.
Then,
incorporation
into
impact
steam
sterilization
nanocomposite
evaluated
concerning
sol-gel
transition,
injectability,
physicochemical
stability.
All
formulations
extruded
through
tested
syringe-needle
systems
acceptable
force
(2.2-13.4
N)
(49.5-317.7
N·mm)
injection.
Following
sterilization,
injection
became
easier
in
most
cases,
properties
all
remained
practically
unchanged
according
spectroscopical
thermal
analysis.
The
rheological
evaluation
revealed
that
liquid
25
underwent
rapid
gelation
37
°C.
sterilized
counterparts
gelled
1-2
above
body
temperature,
suggesting
autoclaving
conditions
employed
had
rendered
these
unsuitable
delivery.
Journal of Materials Chemistry B,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Nanoparticles
capable
of
dynamically
reporting
their
structural
integrity
in
real-time
are
a
powerful
tool
to
guide
the
design
drug
delivery
technologies.
Particulate Science And Technology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 17
Published: March 14, 2025
Lopinavir
(LPV)
presents
significant
challenges
in
HIV
management
due
to
its
poor
permeability
and
low
solubility.
This
study
focuses
on
the
formulation,
optimization,
characterization
of
nanostructured
lipid
carriers
(NLC)
enriched
with
TPGS
enhance
delivery
bioavailability
antiretroviral
drugs
(ARDs).
LPV-NLC
was
developed
using
a
modified
solvent
emulsification
method
optimized
by
employing
quality-by-design
(QbD)
approach.
The
NLC
formulation
incorporated
TPGS,
achieving
globule
size
99.19
±
4.68
nm,
high
entrapment
efficiency
90.2
2.8%,
polydispersity
index
(PDI)
0.236
0.025.
Ex-vivo
studies
demonstrated
1.67-fold
increase
flux,
highlighting
superiority
LPV-TPGS-NLC
over
LPV-S.
Pharmacokinetic
evaluation
revealed
3.40-fold
enhancement
for
LPV-TPGS-NLC,
peak
plasma
concentration
(Cmax)
1320.03
79.12
ng/mL,
approximately
twice
that
These
findings
underscore
potential
TPGS-enriched
as
novel
drug
platform
improving
oral
therapeutic
efficacy
LPV.
enhanced
achieved
this
could
enable
dose
reduction,
thereby
minimizing
associated
side
effects
patient
compliance
therapy.